论文部分内容阅读
目的:针对中药房调剂质量对于临床用药安全的影响情况进行分析。方法:针对我院中药房调剂质量监管体系的建立方案以及评价方式、注意事项实施回顾性的分析,统计并对比建立监管体系前后产生的药物不良事件情况。结果:在监管体系建立前(2013年4月至2014年4月)随机选取的80例患者中,药物不良事件发生率为18.75%,在监管体系建立并实施后(2014年5月至2015年5月)随机选取的80例患者中,药物不良事件发生率为3.75%,研究组明显少于参照组,P<0.05。结论:将中药房操作程序进行规范,同时提升处方审查力度,充分保障调剂的质量,可以显著保障临床用药安全可靠性。
OBJECTIVE: To analyze the influence of the quality of the medicine pharmacy on the safety of clinical medication. Methods: According to our hospital pharmacy transfer quality supervision system establishment plan as well as the appraisal way, the matters needing attention to carry out the retrospective analysis, statistics and contrast establishes before and after the supervisory system produces the medicine adverse event situation. Results: Of the 80 patients randomized before the regulatory system was established (April 2013 to April 2014), the incidence of adverse drug events was 18.75%. After the regulatory system was established and implemented (May 2014 to 2015 May) randomly selected 80 patients, the incidence of adverse drug events was 3.75%, the study group was significantly less than the reference group, P <0.05. Conclusion: It is necessary to standardize the operating procedure of TCM pharmacy and enhance the examination of prescription. The quality of mediation is fully guaranteed, which can significantly ensure the safety and reliability of clinical medication.